Back to news

Nanox Announces That Board Has Approved Cost Reduction and Operational Efficiency Measures

Globe Newswire•09/11/2026•17:47 ET
0

Key Highlights

  • ➤Operating expenses targeted to fall 25%–30% versus annualized 2026 expenses
  • ➤Measures expected fully implemented by end of Q1 2027
  • ➤Workforce reductions and operational adjustments aim to reduce ongoing cash burn
  • ➤Nanox warns recurring losses and negative cash flows create substantial going-concern doubt
  • ➤Additional financing expected, with no assurance it will be available on acceptable terms

Expert Statements

Erez Meltzer, Chief Executive Officer and Acting Chairman of Nanox

“Our objective is to translate Nanox’s technological and clinical progress into measurable commercial performance while strengthening our financial foundation”

Erez Meltzer, Chief Executive Officer and Acting Chairman of Nanox

“We are taking important steps across four priorities: accelerating Nanox.ARC adoption and NIN utilization, deepening commercial and strategic partnerships, improving operational efficiency, and enhancing financial resilience.”

Erez Meltzer, Chief Executive Officer and Acting Chairman of Nanox

“At the same time, we intend to preserve the critical innovation, regulatory and commercial capabilities needed to support our customers, channel partners and installed base.”

Erez Meltzer, Chief Executive Officer and Acting Chairman of Nanox

“We believe this balanced approach is necessary to advance commercialization with greater discipline and accountability, while recognizing the financial challenges we face.”

Erez Meltzer, Chief Executive Officer and Acting Chairman of Nanox

“We remain focused on managing our resources carefully and prioritizing the activities we believe are most important to our business.”

The Board approved plan targets a 25%–30% reduction in annualized operating expenses, compared to annualized 2026 GAAP and non-GAAP operating expenses, once fully implemented, expected by the end of Q1 2027

Cost reduction aims to advance four strategic priorities: Nanox.ARC and Nanox Imaging Network (NIN) commercialization; commercial partnerships and business development; operational efficiency; and strengthening financial resources

Get started

Create a free account to read the full story.

Sign Up

Already have an account? Log in